Literature DB >> 33709127

EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group.

Matteo Bassetti1,2, Elie Azoulay3,4, Bart-Jan Kullberg5, Markus Ruhnke6, Shmuel Shoham7, Jose Vazquez8, Daniele Roberto Giacobbe1, Thierry Calandra9.   

Abstract

The EORTC/MSGERC recently revised and updated the consensus definitions of invasive fungal disease (IFD). These definitions primarily focus on patients with cancer and stem cell or solid-organ transplant patients. They may therefore not be suitable for intensive care unit (ICU) patients. More in detail, while the definition of proven IFD applies to a broad range of hosts, the categories of probable and possible IFD were primarily designed for classical immunocompromised hosts and may therefore not be ideal for other populations. Moreover, the scope of the possible category of IFD has been diminished in the recently revised definitions for classically immunocompromised hosts. Diagnosis of IFD in the ICU presents many challenges, which are different for invasive candidiasis and for invasive aspergillosis. The aim of this article is to review progresses made in recent years and difficulties remaining in the development of definitions applicable in the ICU setting.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  biomarker; definition; histology; invasive aspergillosis (IA); invasive candidiasis (IC)

Year:  2021        PMID: 33709127     DOI: 10.1093/cid/ciaa1751

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019.

Authors:  Jeremy A W Gold; Andrew Revis; Stepy Thomas; Lewis Perry; Rebekah A Blakney; Taylor Chambers; Meghan L Bentz; Elizabeth L Berkow; Shawn R Lockhart; Colleen Lysen; Natalie S Nunnally; Alexander Jordan; Hilary C Kelly; Alejandro J Montero; Monica M Farley; Nora T Oliver; Stephanie M Pouch; Andrew S Webster; Brendan R Jackson; Karlyn D Beer
Journal:  Open Forum Infect Dis       Date:  2022-04-21       Impact factor: 4.423

2.  Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: a Step toward Dose Optimization Using Monte Carlo Simulation.

Authors:  Jiao Xie; Qianting Yang; Xinyan Han; Yuzhu Dong; Tao Zhang; Youjia Li; Meixi Ji; Chenwei Liu; Yan Cai; Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2022-05-23       Impact factor: 5.938

3.  Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.

Authors:  Matthias Egger; Samuel Penziner; Karl Dichtl; Max Gornicec; Lisa Kriegl; Robert Krause; Ethan Khong; Sanjay Mehta; Milenka Vargas; Sara Gianella; Magali Porrachia; Jeffrey D Jenks; Iswariya Venkataraman; Martin Hoenigl
Journal:  J Clin Microbiol       Date:  2022-03-30       Impact factor: 11.677

4.  Putative invasive pulmonary aspergillosis in apparently immunocompetent patients within medical wards and intensive care units.

Authors:  Babatunde Edun; Mark Alan Tidswell
Journal:  Intern Emerg Med       Date:  2021-05-17       Impact factor: 3.397

5.  A novel algorithm for diagnosis of invasive pulmonary aspergillosis based on pentraxin 3 gene polymorphisms and its adjusted value among autoimmune diseases patients.

Authors:  Yuetian Yu; Chunyan Liu; Cheng Zhu; Han Zhong; Zhichun Gu; Chunhui Xu; Chun Pan; Zhijun Xu; Zhixiong Wu; Wenjuan Wu; Liangjing Lu
Journal:  Ann Transl Med       Date:  2022-01

6.  Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate.

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Open Forum Infect Dis       Date:  2022-03-03       Impact factor: 3.835

Review 7.  Invasive mould disease in fatal COVID-19: a systematic review of autopsies.

Authors:  Brittany E Kula; Cornelius J Clancy; M Hong Nguyen; Ilan S Schwartz
Journal:  Lancet Microbe       Date:  2021-06-23

8.  T2Candida Assay in the Diagnosis of Intraabdominal Candidiasis: A Prospective Multicenter Study.

Authors:  Anders Krifors; Måns Ullberg; Markus Castegren; Johan Petersson; Ernesto Sparrelid; Helena Hammarström; Jan Sjölin; Volkan Özenci; Ola Blennow
Journal:  J Fungi (Basel)       Date:  2022-01-16

9.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17

10.  Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.

Authors:  Martin Hoenigl; Matthias Egger; Johannes Boyer; Eduard Schulz; Juergen Prattes; Jeffrey D Jenks
Journal:  Mycoses       Date:  2021-07-24       Impact factor: 4.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.